Veracyte partners with J&J on development of lung cancer test


Veracyte partners with J&J on development of lung cancer test

The deal, with J&J Innovation and the drugmaker’s lung cancer initiative, includes a $5 million upfront payment and up to $15 million in milestones.



Source: http://bit.ly/2F701hZ

Post a Comment

0 Comments